RAB9A and neoplasm: Regarding miR-5010, no functional or clinical studies have been published yet; however, a number of genes are predicted to be targets of this miRNA with high relevance to tumor progression, among others, member of RAS oncogene family (RAB9A), APC membrane recruitment protein 1 (AMER1), beta-catenin interacting protein 1 (CTNNBIP1), Ras-related GTP binding D (RRAGD), etc. (miRDB; www.mirdb.org and TargetMiner; www.isical.ac.in).